Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study

Roncolato, FT; Joly, F; O'Connell, R; Lanceley, A; Hilpert, F; Buizen, L; Okamoto, A; ... Friedlander, M; + view all Roncolato, FT; Joly, F; O'Connell, R; Lanceley, A; Hilpert, F; Buizen, L; Okamoto, A; Aotani, E; Pignata, S; Donnellan, P; Oza, A; Avall-Lundqvist, E; Berek, JS; Heitz, F; Feeney, A; Berton-Rigaud, D; Stockler, MR; King, M; Friedlander, M; - view fewer (2017) Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study. The Oncologist , 22 (9) pp. 1117-1124. 10.1634/theoncologist.2017-0047 .

https://ift.tt/2NENUup